Biopharma Shakti: Modi’s Bold Leap to Make India Biopharma Global Leader
Union Budget 2026’s ‘Biopharma Shakti’ initiative marks a transformative Rs 10,000-crore investment, empowering India to slash China dependency in biologics and seize the $250 billion ‘patent cliff’ opportunity by 2030. Spearheaded by Niti Aayog’s High-Level Committee, this visionary plan positions India as a self-reliant hub for biosimilars and emerging biologics,
